@article{9d025c3b22db452789465f3939bc912e,
title = "T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles",
abstract = "CD8+ T cells are a pivotal part of the immune response to viruses, playing a key role in disease outcome and providing long-lasting immunity to conserved pathogen epitopes. Understanding CD8+ T cell immunity in humans is complex due to CD8+ T cell restriction by highly polymorphic Human Leukocyte Antigen (HLA) proteins, requiring T cell epitopes to be defined for different HLA allotypes across different ethnicities. Here we evaluate strategies that have been developed to facilitate epitope identification and study immunogenic T cell responses. We describe an immunopeptidomics approach to sequence HLA-bound peptides presented on virus-infected cells by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Using antigen presenting cell lines that stably express the HLA alleles characteristic of Indigenous Australians, this approach has been successfully used to comprehensively identify influenza-specific CD8+ T cell epitopes restricted by HLA allotypes predominant in Indigenous Australians, including HLA-A*24:02 and HLA-A*11:01. This is an essential step in ensuring high vaccine coverage and efficacy in Indigenous populations globally, known to be at high risk from influenza disease and other respiratory infections.",
keywords = "antigen presentation, CD8 T cell epitopes, epitope discovery, Human Leucocyte Antigen (HLA), immunopeptidome, Indigenous populations, influenza, SARS-CoV-2",
author = "Luca Hensen and Illing, {Patricia T.} and Rowntree, {Louise C.} and Jane Davies and Adrian Miller and Tong, {Steven Y.C.} and Habel, {Jennifer R.} and {van de Sandt}, {Carolien E.} and Katie L Flanagan and Purcell, {Anthony W.} and Katherine Kedzierska and Clemens, {E. Bridie}",
note = "Funding Information: LH received funding from a Melbourne International Research Scholarship (MIRS) and Melbourne International Fee Remission Scholarship (MIFRS) from The University of Melbourne. ST is a NHMRC Career Development Fellow (#1145033). JH is supported by a Melbourne Research Scholarship from the University of Melbourne. CS has received funding from the European Union{\textquoteright}s Horizon 2020 research and innovation program under the Marie Sk{\l}odowska-Curie grant agreement (#792532). KF received funding from a Clifford Craig Foundation Grant (#145). AP is supported by an NHMRC Principal Research Fellowship (#1137739) and NHMRC Project Grant (#1085018). EC is a NHMRC Peter Doherty Fellow (#1091516). KK is supported by a NHMRC Senior Research Fellowship (#1102792), NHMRC Program Grant (#1071916), NHMRC Investigator Grant (#1173871) and NHMRC Project Grant (#1122524) to KK, ST, AM, and AP. ",
year = "2022",
month = may,
day = "6",
doi = "10.3389/fimmu.2022.812393",
language = "English",
volume = "13",
pages = "1--23",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
}